Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP

N-(3-fluoro-1-phenethylpiperidine-4-yl)-N-phenyl propionamide is a newly-designed pain killer selectively activating G-protein-coupled mu-opioid receptors (MOR) in acidic injured tissues, and therefore devoid of central side effects which are typically elicited at normal pH values in healthy tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Celik, Melih Özgür, Seitz, Viola, Yergöz, Fatih, Dembla, Sandeep, Blum, Nina Kathleen, Schulz, Stefan, Stein, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213447/
https://www.ncbi.nlm.nih.gov/pubmed/37251645
http://dx.doi.org/10.3389/fnmol.2023.1171855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213447/
https://www.ncbi.nlm.nih.gov/pubmed/37251645
http://dx.doi.org/10.3389/fnmol.2023.1171855

Ejemplares similares